Valuation: MedPacto, Inc.

Market Cap 8.74TCr 6.31Cr 5.4Cr 5.05Cr 4.63Cr 8.68Cr 603.4Cr 8.8Cr 60Cr 23Cr 303.12Cr 24Cr 23Cr 1TCr P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 4.84TCr 3.49Cr 2.99Cr 2.8Cr 2.56Cr 4.81Cr 334.34Cr 4.88Cr 33Cr 13Cr 167.95Cr 13Cr 13Cr 555.52Cr EV / Sales 2024
-
EV / Sales 2025 4,87,33,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day-1.54%
1 week-5.20%
Current month+8.51%
1 month-2.86%
3 months-34.53%
6 months-55.65%
Current year-61.83%
1 week 2,390
Extreme 2390
2,825
1 month 2,235
Extreme 2235
3,960
Current year 2,235
Extreme 2235
7,980
1 year 2,235
Extreme 2235
8,650
3 years 2,235
Extreme 2235
17,240
5 years 2,235
Extreme 2235
69,600
10 years 2,235
Extreme 2235
1,34,200
Manager TitleAgeSince
Chief Executive Officer 72 19/06/2013
President 66 28/03/2024
Comptroller/Controller/Auditor 70 28/03/2022
Director TitleAgeSince
Director/Board Member 72 19/06/2013
Director/Board Member 66 28/03/2024
Director/Board Member 64 28/03/2024
Date Insider Type Main position Quantity % Market Cap.
04/03/25 Buy 10,000 0.0292%
04/03/25 Buy 10,500 0.0306%
04/03/25 Buy

Chairperson

15,000 0.0438%
Change 5-day change 1-year change 3-year change Capi.($)
-1.54%-5.20%-34.11%-82.51% 6.31Cr
-3.00%+2.27%+77.60%+109.33% 7.21TCr
+1.90%+23.53%+56.60%+97.76% 6.59TCr
+5.12%+25.22%+5.24%-0.82% 2.93TCr
+0.55%+1.64%-5.15%+471.68% 2.75TCr
+2.74%+12.98%+62.84%+28.14% 2.67TCr
+0.47%+6.12%+36.66%-13.79% 2.01TCr
+1.82%-6.67%+247.46%+393.10% 1.82TCr
+0.94%+3.36%+18.55%+532.94% 1.64TCr
+0.73%+5.54%+39.71%+153.07% 1.34TCr
Average +0.97%+7.01%+50.54%+168.89% 2.9TCr
Weighted average by Cap. +0.74%+9.48%+59.02%+157.75%

Financials

2024 2025
Net sales - 3.9T 2.81 2.41 2.25 2.06 3.87 269.14 3.92 26.64 10.39 135.2 10.56 10.33 447.2
Net income -2.01TCr -1.45Cr -1.24Cr -1.16Cr -1.07Cr -2Cr -139.05Cr -2.03Cr -14Cr -5.37Cr -70Cr -5.46Cr -5.34Cr -231.03Cr -1.28TCr -92.44L -79.18L -74.09L -67.82L -1.27Cr -88Cr -1.29Cr -8.75Cr -3.41Cr -44Cr -3.47Cr -3.4Cr -146.95Cr
Net Debt -5.35TCr -3.86Cr -3.31Cr -3.1Cr -2.83Cr -5.32Cr -369.62Cr -5.39Cr -37Cr -14Cr -185.67Cr -15Cr -14Cr -614.13Cr -3.9TCr -2.81Cr -2.41Cr -2.25Cr -2.06Cr -3.87Cr -269.06Cr -3.92Cr -27Cr -10Cr -135.16Cr -11Cr -10Cr -447.06Cr
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
-
Date Price Change Volume
21/26/21 ₩2,550.00 -1.54% 1,10,012
20/26/20 ₩2,590.00 +6.37% 3,48,594
19/26/19 ₩2,435.00 -3.75% 1,11,377
18/26/18 ₩2,530.00 -5.95% 1,41,822
14/26/14 ₩2,690.00 -1.47% 87,804
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A235980 Stock